5

6-7 NEWS
AbbVie to acquire Apogee for $10.9bn; Vertex to acquire Crinetics for $10bn

8-9 NEWS
Gilead’s Trodelvy approved by EC for breast cancer; Biogen and Eisai’s Leqembi study of early Alzheimer’s

10 DERMATOLOGY NEWS
Almirall’s Ebglyss for atopic dermatitis; Veradermics for female pattern hair loss

12 DARWIN’S MEDICINE
The epidemiology of ideas

13 TRUST ISN’T WHAT IT USED TO BE
HCPs are competing with social media

14 FOUR POSITIONING CHALLENGES
Helping teams from early strategy to execution

15 FUTURE OF HEALTHCARE COMMS
Communiqué Awards 2026 and the industry

16-17 LUPUS – RESETTING THE IMMUNE SYSTEM
Translating emerging science into care that works meaningfully in practice: ASCO 2026 wasn't just about hazard ratios and first-in-class molecules, but about how we translate scientific progress into better outcomes for patients

18-19 GLP-1s AND THE CONSUMER LIFESTYLE SHIFT
The UK’s challenge is less about capability and more about how global pharma now operates. Pharmaceutical companies are allocating capital based on where they can achieve the strongest and most sustainable return

22-28 COMMUNIQUÉ AWARDS 2026 – CELEBRATING EXCELLENCE IN HEALTHCARE COMMUNICATIONS
The PMEAs, with a team of over 20 judges from different companies, healthcare organisations, academia and charities, celebrate excellence within the pharmaceutical, biotech and medtech sectors

30-31 FORGING A CONNECTION THROUGH CREATIVITY
GenAI is flourishing across drug discovery, clinical trials and healthcare system recalibration, but many fear its potential power is dissipating through a lack of co-ordinated application across departments

33-35 LEADING THROUGH COMPLEXITY
Making launch more precise, cost-effective and agile demands new thinking and new technologies. Pharma companies are launching more innovative products while facing faster, fiercer competition

36-37 SUPPLY CHAIN MANAGEMENT
Over time, the use of AI agents will support a broader range of launch processes and workflows, enabling teams to move faster, make more informed decisions and operate with greater efficiency

38-39 CREATING A STRONG PATENT PORTFOLIO
Over time, the use of AI agents will support a broader range of launch processes and workflows, enabling teams to move faster, make more informed decisions and operate with greater efficiency

June/August 2026